Sensitive Immunocytochemical Method for Identification of Estrogen Receptor Positive Subpopulations of Breast Cancer Cells

References

• Hubai CA, Pearson O, Marshal JE et al: Adjuvant therapy of stage two breast cancer. 48 months follow up of a prospective randomized clinical trial. Breast Cancer Research Treat 9: 72–89, 1981.
   Google Scholar
• Bishop HM, Elston SW, Nicholson RI et al: Relationship of estrogen receptor status to survival of breast cancer. Lancet 2:283–284, 1979.
   PubMed Web of Science ®Google Scholar
• McGuire WI: Hormone receptors; their role in predicting prognosis and response to endocrine therapy. Semin Oncol 5:428–433, 1978.
   PubMed Web of Science ®Google Scholar
• De Sombre E, Green G, Jensen E: In Breast Cancer: New Concepts in Etiology, and Control, MB Brennan and CM McGrath (eds). Academic Press, New York, 1980, pp 69–87.
   Google Scholar
• McClelland J, Berger U, Miller L et al: Immunohistochemical assay of estrogen receptors in patients with breast cancer; relationship to a biochemical assay and to outcome to therapy. J Clin Oncol 4:1171–1176, 1986.
   PubMed Web of Science ®Google Scholar
• Press M, Greene G: Immunocytochemical localization of estrogen and progesteron receptors. In Advances in Immunocy-tochemistry. De Lellis R (ed). Raven Press, New York, 1988, pp 341–358.
   Google Scholar
• Immunocytochemical assay for detection of human estrogen receptor. Abbott Laboratories, Chicago Ill, 1988.
   Google Scholar
• Markovic O, Somers R, Daskal I: Quantitation of immunocy-tochemical expression of estrogen receptors on single breast cancer cells. J Histochem Cytochem 89:93, 1989.
   Google Scholar
• Markovic O, Daskal I, Somers R: Unpublished data.
   Google Scholar
• Ackerman LV, Regato JA: Cancer, Diagnosis, Treatment and Prognosis, 4th ed. CV Mosby Co, St. Louis, MO, 1970, pp 830–864.
   Google Scholar
• Brennan MJ: Breast Cancer. In Cancer Medicine, Holland JH, Frei E, III, (eds). Lea and Febiger, Philadelphia, PA, 1974, pp. 1769–1788.
   Google Scholar
• Chamnes G, Huff K et al: Protamine precipitated estrogen receptor: a solid phase ligand exchange assay. J Steroid Biochem 20:51–61, 1984.
   PubMedGoogle Scholar
• ATCC Catalogue of Cell Lines and Hybridomas, 6th ed. American Type Culture Collection, Rockville, MD, 1988, p 20.
   Google Scholar
• Markovic O, Markovic N, Rakic LJ: Quantitative Cytochemistry of Enzymes. University Press, Belgrade, 1988, pp 40–52.
   Google Scholar
• Markovic N, Markovic O, Young D et al: Computerized Cell Image Tomography: advances in cell imaging. Second Conference on Quantitative Histopathology, WRAIR, Bethesda, MD, Abstracts 1:65, 1987.
   Google Scholar
• Markovic O, Young D, Markovic N: Quinidine induced decrease of esterase activity in hepatoma cell line. Clin Chem 34:512–519, 1988.
   PubMed Web of Science ®Google Scholar
• Editorial note. Clin Chem 35:509, 1989.
   Google Scholar
• Pefios T, Westgard O: Evaluation of methods. In The Text-book of Clinical Chemistry. Tietz N, (ed). W. Saunders Co, 1986.
   Google Scholar
• Cheng L, Binders S, Fu Y et al: Demonstration of estrogen receptors by monoclonal antibody in formalin fixed breast tumors. Lab Invest 58:346–353, 1988.
   PubMed Web of Science ®Google Scholar
• Franclin W, Bilbo M et al: Quantitation of estrogen receptor content and Ki-67 staining in breast carcinoma by the Micro Ticas Image Analysis System. J Anal Quantitative Cytol Histol. 9:279–286, 1987.
   PubMed Web of Science ®Google Scholar
• Cell Analysis System. Product specification: CAS 100, 1987 and CAS 200, 1988.
   Google Scholar
• Charpin C, Martin MP, De Victor B: Multiparametric study (SAMBA 200) of estrogen receptor immunohistochernical assay in 400 human breast carcinoma. Cancer Res 48:1578-1586, 1988.
   Google Scholar
• Skarlew R, Pertschuk L: Quantitation of the firununocyto-chemical assay for estrogen receptor protein (ERICA) in human breast carcinoma by television imaging. J Histochem Cytochem 35:1253–1259, 1987.
   PubMedGoogle Scholar
• Walker K, Bouzubar N, Robertson J et al: Immunocytochemical localization of estrogen receptors in human breast tissue. Cancer Res 48:6517–6522, 1988.
   PubMed Web of Science ®Google Scholar
• Parl F, Possey J: Discrepancies of the biochemical and immunohistochemical estrogen receptor assay in breast cancer. Hum Pathol 19:960–966, 1988.
   PubMed Web of Science ®Google Scholar
• Alemco H, Heinonen E, Sheinin TM et al: Estrogen and progesterone receptors and disease free interval in primary breast cancer. Br J Cancer 50:667–672, 1984.
   PubMed Web of Science ®Google Scholar
• Shimada A, Kimura S et al: Irrununocytochemical staining of estrogen receptors in paraffin sections of human breast cancer using monoclonal antibody. Proc Natl Acad of Sci 82:4803–4807, 1985.
   PubMed Web of Science ®Google Scholar
• Leith T, Dexter D: Mammalian Tumor Cell Heterogeneity. CRC Press Inc, Boca Raton, FL, 1986, pp 79–93.
   Google Scholar
• Devleeshouwe N, Faveoly D et al: Comparison of biochemical and immunoenzymatic.macromethod and a new immuno-cytochemical micromethod for assay of estrogen receptors in human breast cancer. Acta Cytol 32:816–825, 1988.
   PubMedGoogle Scholar
• Poulsen HS, Jensen J et al: Human breast cancer heterogeneity of estrogen receptor cites. Cancer 43:791–793, 1987.
   Google Scholar